Apple vs Eli Lilly and: Business Model & Financial Comparison 2026
Apple · Technology / Consumer Electronics·Eli Lilly and · Healthcare / Drug Manufacturers - General
Financial Comparison
| Metric | AAPLApple | LLYEli Lilly and |
|---|---|---|
| Market Cap | $3.68T | $881.67B |
| Revenue (TTM) | $435.62B | $65.18B |
| Revenue Growth | 15.7% | 42.6% |
| Gross Margin | 47.3% | 83.0% |
| Operating Margin | 35.4% | 44.9% |
| Net Margin | 27.0% | 31.7% |
| Return on Equity | 152.0% | 101.2% |
| P/E (Trailing) | 31.7x | 42.9x |
| P/E (Forward) | 26.9x | 23.5x |
| Free Cash Flow | $106.31B | $1.95B |
| Cash | $66.91B | $7.27B |
| Total Debt | $90.51B | $43.87B |
Data sourced from Yahoo Finance. Green highlights indicate better performance for that metric. Use the interactive tool for real-time data.
Business Model Comparison
Apple
Apple stands as the world's most valuable company and leader in consumer electronics. Generating $435.62 billion in annual revenue (growing 15.7% year-over-year) and carrying a market capitalization of $3.83 trillion, the company has cemented its position as a foundational player in the global Consumer Electronics landscape. Under the leadership of Tim Cook, Apple continues to execute on a multi-year strategic vision that balances growth investme…
Full Apple analysis →Eli Lilly and
Eli Lilly and Company stands as a leading company in Healthcare. Generating $65.18 billion in annual revenue (growing 42.6% year-over-year) and carrying a market capitalization of $880.04 billion, the company has cemented its position as a foundational player in the global Drug Manufacturers - General landscape. Under the leadership of its leadership team, Eli Lilly and Company continues to execute on a multi-year strategic vision that balances g…
Full Eli Lilly and analysis →SWOT Analysis Comparison
Strengths
Apple
- With a market capitalization of $3.83T, Apple is one of the largest companies in its sector, providing the scale advantages of brand recognition, supplier leverage, and capital access that smaller com
- Apple's gross margin of 47.3% is well above industry averages, reflecting pricing power, operational efficiency, or a high-value product mix. The operating margin of 35.4% demonstrates disciplined cos
- Revenue grew 15.7% year-over-year to $435.62B, indicating strong demand for Apple's products and services and outperformance relative to many industry peers.
Eli Lilly and
- With a market capitalization of $880.04B, Eli Lilly and Company is one of the largest companies in its sector, providing the scale advantages of brand recognition, supplier leverage, and capital acces
- Eli Lilly and Company's gross margin of 83.0% is well above industry averages, reflecting pricing power, operational efficiency, or a high-value product mix. The operating margin of 44.9% demonstrates
- Revenue grew 42.6% year-over-year to $65.18B, indicating strong demand for Eli Lilly and Company's products and services and outperformance relative to many industry peers.
Weaknesses
Apple
- With a debt-to-equity ratio of 102.6, Apple carries significant debt relative to equity. While manageable given its cash flow, elevated leverage limits financial flexibility and increases vulnerabilit
- With 150,000 employees globally, Apple faces inherent challenges in agility, decision-making speed, and maintaining a consistent culture across geographies — advantages that smaller, nimbler competito
- iPhone revenue still represents 52% of total sales — over-reliance on a single product
Eli Lilly and
- With a debt-to-equity ratio of 165.3, Eli Lilly and Company carries significant debt relative to equity. While manageable given its cash flow, elevated leverage limits financial flexibility and increa
Opportunities
Apple
- The rapid advancement of generative AI and large language models presents Apple with opportunities to automate operations, enhance products, and develop new AI-native services. Companies in Technology
- Apple operates in the Consumer Electronics segment of the broader Technology sector, which represents a $5.0 trillion by 2027 (IDC Global Technology Market). Even modest share gains in this environmen
- Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Apple's
Eli Lilly and
- Eli Lilly and Company operates in the Drug Manufacturers - General segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains i
- Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Eli Lil
- Earnings growth of 51.4% YoY demonstrates Eli Lilly and Company's ability to convert revenue growth into shareholder value. Analysts project continued earnings expansion driven by operating leverage a
Threats
Apple
- Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. Apple's revenue is not fully insulated from macroeconomic cycles, and a recession scenario c
- Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on Apple's business mo
- The technology sector evolves at a pace where today's competitive advantages can erode quickly. New entrants with AI-native approaches, open-source alternatives, or disruptive business models could ch
Eli Lilly and
- Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. Eli Lilly and Company's revenue is not fully insulated from macroeconomic cycles, and a rece
- Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on Eli Lilly and Compa
- Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly cri
Compare any 2–4 companies with live data
The interactive comparison tool lets you select any companies, see real-time metrics, and export a side-by-side report.
Open Comparison ToolApple vs Eli Lilly and: FAQ
- Is Apple bigger than Eli Lilly and?
- By market capitalization, Apple is larger at $3.68T vs Eli Lilly and's $881.67B.
- Which has better profit margins — Apple or Eli Lilly and?
- Eli Lilly and has higher net profit margins (31.7%) compared to Apple (27.0%). Gross and operating margins are compared in the table above.
- What sectors do Apple and Eli Lilly and operate in?
- Apple operates in the Technology sector (Consumer Electronics). Eli Lilly and operates in the Healthcare sector (Drug Manufacturers - General).
- How does Apple's revenue compare to Eli Lilly and's?
- Apple generates $435.62B in annual revenue (TTM) while Eli Lilly and generates $65.18B. Apple is the larger company by revenue as of 2026.